Koselugo 7.5 mg granules in capsule for opening

Licence holder

AstraZeneca AB (all products →)

Active substance

Selumetinib Sulfate

Dosage form

Granules in capsule for opening

Route of administration

Oral use

ATC code

L01EE04

First authorised

09/01/2026

Prescription status

Product subject to prescription which may not be renewed (A)

Supply

Supply through pharmacies only

Legal basis

Full application (Article 8(3) of Directive No 2001/83/EC)

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.